“The venture reflects Mayo Clinic’s commitment to serve patients and medical providers around the world by sharing our knowledge in new ways, improving global health and advancing healthcare delivery,” spokesman Bryan Anderson said on Monday.
Last June, GMR Group spoke with various potential hospitals, including Mayo Clinic, about a potential $1 billion hospital project in Hyderabad, one of the most populous cities in the country. Anderson did not comment on the status of this possible joint-venture project, nor would he answer any other questions about the Indian market or Mayo’s interests there.
Mayo Clinic seems to have international expansion on the horizon. They recently signed an agreement to collaborate with International Clinical Research Center, a European Union-funded research center in the Czech Republic. Last June, Mayo Clinic signed a deal to work with physicians in China, and it recently added Spanish-language healthcare social media to accommodate Mayo patients from Central and South America.
And Mayo Clinic has long worked on strengthening its ties with the medical community in India, visiting major cities and meeting with hospital group leaders. In particular, Mayo has focused its efforts around diabetes.
Mayo’s expansion overseas would be a little late to the party compared to its American competitors. Johns Hopkins has a research center in Singapore and Cleveland Clinic has planted its flag in the Middle East with its venture in Abu Dhabi, among other places. It’s unclear what percentage of Mayo’s current international patient population comes from India.
There may need to be talk of an “India bubble” pretty soon in the life sciences and healthcare. Along with Mayo’s interest, Medtronic is planning to get much more aggressive there, as are other medical device companies. Many are attracted to an Indian healthcare system largely based on patient pay.